Isabl Inc. is a biotechnology startup that focuses on developing whole-genome and RNA sequencing diagnostic assays for cancer. The company was founded in 2020, following a period of technology incubation at MSKCC from 2015 to 2019. Isabl also participated in Y Combinator's Winter 2020 batch. Notably, the company secured $3M in seed funding from Two Sigma Ventures, Y Combinator, and BoxOne Ventures, showcasing confidence from prominent investors. In 2021, Isabl received FDA Breakthrough Device designation, recognizing the potential impact of its cancer diagnostic tests. Additionally, the company was awarded a $2M direct-to-phase-2 SBIR grant from the National Cancer Institute to advance its specialized test targeting pediatric and rare solid cancers, further cementing its position in the industry. With founders Dr. Elli Papaemmanuil, Dr. Andrew Kung, and Juan Medina at the helm, Isabl amalgamates deep expertise in precision medicine, computational biology, and software engineering, supported by a strong track record in biomarker discovery and clinical decision support.
Isabl Inc.
Pioneering precise cancer diagnostics through advanced sequencing technology and expert-driven research.
General Information
Get notified when Isabl Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Isabl Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Isabl Inc.
Taxonomy: precision medicine, cancer diagnostics, whole-genome sequencing, RNA sequencing, biomarker discovery, clinical decision support, startups, investments, Y Combinator, FDA Breakthrough Device, NCI grant, oncology research, startup funding
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 01 Apr 2023 |
| Seed Round | •••••• | 4 |
|
18 May 2022 |
| Pre Seed Round | •••••• | 1 |
|
01 Jun 2020 |
Isabl Inc. Alternatives & Competitors
Whole-genome analysis and clinical reporting. CapeDx for cancer patients, GulfDx for inherited disea...
Innovating healthcare with a simple blood test for early detection of colorectal cancer and other tu...
FAQ About Isabl Inc.
Don't just browse. Track.
Signal Tracker monitors Isabl Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
